Bumper Offer - Urjas oil Just @ Rs. 1
Levesam 500 Tablet XR (10) is a prescription drug, available for use as Tablet. It is primarily used for the treatment of Epilepsy. The alternative uses of Levesam 500 Tablet XR (10) have also been explained below.
The right dosage of Levesam 500 Tablet XR (10) depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
The side effects typically associated with Levesam 500 Tablet XR (10) include Fatigue, Headache, Drowsiness. While these are the most often observed Levesam 500 Tablet XR (10) side effects, there are can be others also. These have been listed below. Usually, these side effects of Levesam 500 Tablet XR (10) go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
Levesam 500 Tablet XR (10)'s effect during pregnancy is Moderate and Mild while nursing. Further, the section on Levesam 500 Tablet XR (10) related warnings talks about Levesam 500 Tablet XR (10)'s effects on the liver, heart and kidney.
Some other conditions that can be affected by Levesam 500 Tablet XR (10) are listed in the contraindications section below.
Drug interactions for Levesam 500 Tablet XR (10) have been reported in the medical literature. See below for a complete list.
In addition to these precautions, you may also note that Levesam 500 Tablet XR (10) is not safe while driving, and is is not addictive in nature.
Levesam 500 Tablet XR (10) is used to treat the following -
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Levesam 500 Tablet XR (10) is used -
Moderate
Mild
Common
Is the use of Levesam 500 Tablet XR (10) safe for pregnant women?
Pregnant women may experience moderate side effects from Levesam. It is best to stop taking Levesam immediately and inform your doctor if you notice any discomfort.
Is the use of Levesam 500 Tablet XR (10) safe during breastfeeding?
Levesam may have very limited harmful effects for breastfeeding women.
What is the effect of Levesam 500 Tablet XR (10) on the Kidneys?
Very few cases of side effects of Levesam on kidney have been reported.
What is the effect of Levesam 500 Tablet XR (10) on the Liver?
Levesam has very mild side effects on the liver.
What is the effect of Levesam 500 Tablet XR (10) on the Heart?
Levesam is not harmful for the heart.
Levesam 500 Tablet XR (10) should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Levesam 500 Tablet XR (10) unless your doctor advises you to do so -
Is this Levesam 500 Tablet XR (10) habit forming or addictive?
Levesam 500 Tablet XR (10) is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Levesam 500 Tablet XR (10) you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, Levesam 500 Tablet XR (10) is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
Yes, this Levesam 500 Tablet XR (10) works for mental disorders.
Interaction between Food and Levesam 500 Tablet XR (10)
You can take Levesam 500 Tablet XR (10) with food.
Interaction between Alcohol and Levesam 500 Tablet XR (10)
Consuming Levesam 500 Tablet XR (10) with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
